Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity

Abstract

Macrovascular disease, including coronary artery disease and cerebrovascular disease, is one of the leading causes of morbidity and mortality for patients with type 2 diabetes. As a result, clinical guidelines for the management of type 2 diabetes emphasize lowering macrovascular disease risk factors by optimizing glycemic control, blood pressure, and serum lipid levels.^1,2 This multifactorial approach has been shown to substantially reduce the incidence of macrovascular complications.^2,3 However, most patients with type 2 diabetes do not achieve these recommended treatment goals,⁴ resulting in continued morbidity and costs.